ScholarIQanswers from OpenAlex & ORCID
Clemens‐Martin Wendtner
ResearcherPublications, citations & collaboration network
Clemens‐Martin Wendtner is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Clemens‐Martin Wendtner have?
ScholarIQindexed works
Clemens‐Martin Wendtner has 434 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Clemens‐Martin Wendtner have?
ScholarIQcitation count
Clemens‐Martin Wendtner has 26,457 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Clemens‐Martin Wendtner?
ScholarIQh-index
Clemens‐Martin Wendtner has an h-index of 66 in OpenAlex.
What is the i10-index of Clemens‐Martin Wendtner?
ScholarIQi10-index
Clemens‐Martin Wendtner has an i10-index of 181 in OpenAlex.
What is the ORCID of Clemens‐Martin Wendtner?
ScholarIQorcid
The ORCID for Clemens‐Martin Wendtner is on the source record.
What is the OpenAlex record for Clemens‐Martin Wendtner?
ScholarIQopenalex
The OpenAlex for Clemens‐Martin Wendtner is on the source record.
What are the most-cited papers on Clemens‐Martin Wendtner?
ScholarIQmost cited works
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial
Stephan Stilgenbauer, Andrea Schnaiter, Peter Paschka, Thorsten Zenz, Marianna Rossi, Konstanze Döhner, Andreas Bühler, Sebastian Böttcher, Matthias Ritgen, Michael Kneba, Dirk Winkler, Eugen Tausch, Patrick Hoth, Jennifer Edelmann, Daniel Mertens, Lars Bullinger, Manuela Bergmann, Sabrina Kless, Silja Mack, Ulrich Jäger, Nancy Patten, Lin Wu, Michael Wenger, Günter Fingerle‐Rowson, Peter Lichter, Mario Cazzola, Clemens‐Martin Wendtner, Anna Maria Fink, Kirsten Fischer, Raymonde Busch, Michael Hallek, Hartmut Döhner
Bendamustine in Combination With Rituximab for Previously Untreated Patients With Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
Kirsten Fischer, Paula Cramer, Raymonde Busch, Sebastian Böttcher, Jasmin Bahlo, Jöerg Schubert, Karl Heinz Pflüger, Silke Schott, Valentin Goede, Susanne Isfort, Julia von Tresckow, Anna‐Maria Fink, Andreas Bühler, Dirk Winkler, Karl‐Anton Kreuzer, Peter Staib, Matthias Ritgen, Michael Kneba, Hartmut Döhner, Barbara Eichhorst, Michael Hallek, Stephan Stilgenbauer, Clemens‐Martin Wendtner
Bendamustine Combined With Rituximab in Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia: A Multicenter Phase II Trial of the German Chronic Lymphocytic Leukemia Study Group
Kirsten Fischer, Paula Cramer, Raymonde Busch, Stephan Stilgenbauer, Jasmin Bahlo, Carmen D. Schweighofer, Sebastian Böttcher, Peter Staib, Michael Kiehl, Michael J. Eckart, Gabriele Kranz, Valentin Goede, Thomas Elter, Andreas Bühler, Dirk Winkler, Michael Kneba, Hartmut Döhner, Barbara Eichhorst, Michael Hallek, Clemens‐Martin Wendtner